Detailed Information on Publication Record
2019
A comparative study of myasthenic patients in the Czech and Slovak Republics
HORÁKOVÁ, Magda, I. MARTINKA, Stanislav VOHÁŇKA, P. ŠPALEK, Josef BEDNAŘÍK et. al.Basic information
Original name
A comparative study of myasthenic patients in the Czech and Slovak Republics
Name in Czech
Srovnávací studie pacientů s myastenií České a Slovenské republiky
Authors
HORÁKOVÁ, Magda (203 Czech Republic, guarantor, belonging to the institution), I. MARTINKA (703 Slovakia), Stanislav VOHÁŇKA (203 Czech Republic, belonging to the institution), P. ŠPALEK (703 Slovakia) and Josef BEDNAŘÍK (203 Czech Republic, belonging to the institution)
Edition
Česká a slovenská neurologie a neurochirurgie, Praha, Česká lékařská společnost J.E. Purkyně, 2019, 1210-7859
Other information
Language
English
Type of outcome
Článek v odborném periodiku
Field of Study
30103 Neurosciences
Country of publisher
Czech Republic
Confidentiality degree
není předmětem státního či obchodního tajemství
References:
Impact factor
Impact factor: 0.377
RIV identification code
RIV/00216224:14110/19:00109453
Organization unit
Faculty of Medicine
UT WoS
000462991800006
Keywords in English
myasthenia gravis; population characteristics; comparison; registries
Tags
International impact, Reviewed
Změněno: 11/5/2020 08:50, Mgr. Tereza Miškechová
Abstract
V originále
Aim: Existing epidemiological studies of myasthenia feature differences in incidence, prevalence, age-and gender-specific incidences, mortality rate, and even the prevalence of myasthenia subtypes. The aim of this study was to compare the over all management of patients with myasthenia, the severity of the disease, and a number of clinical and laboratory characteristics and therapy approaches amongst patients in the Czech Republic and the Slovak Republic. Patients and methods: Data were retrospectively collected from two registries in the Czech Republic (Brno) and the Slovak Republic (Bratislava). Data were randomly matched by age of onset of myasthenia and gender. The resulting groups consisted of 152 patients each. Results: There was almost no significant difference between the matched groups. The clinical form, positivity of antibodies to acetylcholine receptor, Myasthenia Gravis Composite Score, time to diagnosis, and percentage of thymomas and thymectomy were not significantly different. There were significant differences only in the occurrence of limb weakness at the onset of disease and in the choice of treatment modality. Conclusions: Our data suggest that at least part of previously observed heterogeneity between populations might be based on different age and gender distribution.
Links
ROZV/25/LF/2017, interní kód MU |
|